Drug Target Review2025-12-04T08:30:48
Researchers at LMU Munich have developed Bits2Bonds, the first platform to fuse molecular simulations with machine learning – accelerating the discovery of polymer carriers for therapeutic RNA.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2026-08-06T06:08:00
Author Dr Jonathan Cohen-Gold
2026-09-18T15:56:00
Contributor Dr Garegin Papoian, Drug Target Review
2026-10-22T15:52:00
Contributor Dr Srijit Seal, Dr Raminderpal Singh
2023-04-17T14:45:00
Sponsored by Sartorius, Drug Target Review
2023-06-13T13:30:40
Sponsored by NanoTemper Technologies
Site powered by Webvision Cloud